Topic

Novo Nordisk

Latest Daily Tribune news and analysis on Novo Nordisk.

Novo pushes new obesity care approach
Novo Nordisk has launched the “Live Lighter” campaign in Makati City alongside a new semaglutide-based therapy, aiming to reshape obesity treatment in the…
25 April 20261 MIN READ
Novo pushes new obesity care approach
Novo Nordisk launches its ‘Live Lighter’ movement in the Philippines, introducing a semaglutide-based obesity treatment and a nationwide push to treat obesity…
24 April 20262 MIN READ
Up to 1.5 million Americans using compounded weight-loss drugs
Up to 1.5 million Americans may be using compounded versions of GLP-1 weight-loss drugs, Novo Nordisk CEO Mike Doustdar said, highlighting how cheaper…
13 January 20262 MIN READ
EMA flags rare vision risk in users of weight-loss drugs
7 June 20252 MIN READ
Novo Nordisk reports 21% profit jump in 2024
Novo Nordisk sees a 21% profit surge in 2024, driven by strong sales of diabetes and weight-loss drugs Ozempic and Wegovy, totaling 100 billion Danish kroner.
5 February 20251 MIN READ